SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-014431
Filing Date
2023-04-25
Accepted
2023-04-25 16:11:13
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A copy_of_definitive_addl_.htm DEFA14A 32194
2 GRAPHIC img241623638_0.jpg GRAPHIC 124945
3 GRAPHIC img241623638_1.jpg GRAPHIC 102613
  Complete submission text file 0000950170-23-014431.txt   346857
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37465 | Film No.: 23844988
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences